Reliable Data You Can Trust
Reliable Data You Can Trust
By Infinium Global Research Aug, 2020
The molecular diagnostic is a collection of techniques used
to analyses biological markers in the genome and proteome. In veterinary
molecular diagnostics, samples that are derived from animals are tested. This
diagnostic mostly focuses on the identification, genotyping of pathogens and
detection. In veterinary diagnosis, these techniques are used to diagnose diseases
in individual animals and groups or to assess the disease status of a group. Growing
consciousness regarding the importance of molecular diagnostics among
veterinarians and the general public in both developed and developing countries
for healthy livestock is estimated to drive the global veterinary molecular
diagnostics market. Further, increasing the incidence of numerous animal diseases
worldwide, and an upsurge in spending on pets are other reasons driving the
growth of this market. Additionally, owing to the increasing incidence of
foodborne zoonotic diseases worldwide the production of animal has reduced by
15%-20% per year. As per the European food safety authority (EFSA), around
3,20,000 cases of foodborne and zoonotic diseases are reported every year.
Therefore, with increasing, consciousness regarding zoonotic diseases such as
bird flu and swine flu farm owners are progressively inclining towards the
appropriate care of livestock through correct and specific diagnosis.
The report on Global Veterinary Molecular Diagnostics Market covers segments such as product, technology, animal type, disease indication, and end-user. The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The report provides profiles of the companies in the global IDEXX Laboratories, Inc., VCA, Inc., Thermo Fisher Scientific, Inc., Novacyt Group, QIAGEN N.V., Biomedica Medizinprodukte GmbH, HealthGene Corporation, Bioneer, Abaxis, Inc. and Neogen Corporation.